Summary
The thousands of microbial species that compose the human gut microbiome are linked to diseases from cancer to diabetes, sparking tremendous interest among pharmaceutical/ medical researchers in microbiome analytics. Current analytics methods are far too slow, expensive, and inaccurate to fulfil this need. Much faster techniques are essential for microbiome tracking over the course of disease states and therapies to discover correlations with disease and enable personalized medicine. Perseus MAP is the only microbiome analytics platform that will be able to handle this onslaught of demand, through a revolutionarily fast, high-throughput, and accurate technology based on DNA imaging techniques invented in the lab of our co-founders. We will massively accelerate microbiomics, starting with a central service lab, deploying satellite labs, and finally producing portable units for the microbiomics mass market, at a capacity of 300k profiles/yr analyzed in-house to seize a €2.5B market.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/190119214 |
| Start date: | 01-10-2021 |
| End date: | 30-09-2023 |
| Total budget - Public funding: | 3 575 740,00 Euro - 2 500 000,00 Euro |
Cordis data
Original description
The thousands of microbial species that compose the human gut microbiome are linked to diseases from cancer to diabetes, sparking tremendous interest among pharmaceutical/ medical researchers in microbiome analytics. Current analytics methods are far too slow, expensive, and inaccurate to fulfil this need. Much faster techniques are essential for microbiome tracking over the course of disease states and therapies to discover correlations with disease and enable personalized medicine. Perseus MAP is the only microbiome analytics platform that will be able to handle this onslaught of demand, through a revolutionarily fast, high-throughput, and accurate technology based on DNA imaging techniques invented in the lab of our co-founders. We will massively accelerate microbiomics, starting with a central service lab, deploying satellite labs, and finally producing portable units for the microbiomics mass market, at a capacity of 300k profiles/yr analyzed in-house to seize a €2.5B market.Status
SIGNEDCall topic
HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01Update Date
09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
